On the REPROCELL blog
Latest
What to Look for in a Global Central Lab Partner for Clinical Trials
Selecting the right global central lab partner is crucial for clinical trial success, impacting data quality, logistics, and regulatory compliance.
14 May 2026
The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment
Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.
30 April 2026
Inside the Sample Lifecycle: How Central Labs Protect Data from Collection to Analysis
Explore how central laboratories safeguard data integrity throughout the sample lifecycle, from collection to analysis, ensuring reliable outcomes in research.
13 April 2026
Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery
Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.
02 April 2026